SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-18-009425
Filing Date
2018-07-03
Accepted
2018-07-03 20:01:02
Documents
2
Period of Report
2018-06-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3988
2 ex24stump.txt EX-24 3638
  Complete submission text file 0001179110-18-009425.txt   9007
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Issuer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
STUMP DAVID C (Reporting) CIK: 0001191235 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51531 | Film No.: 18939194